Institute For Clinical And Experimental Medicine — Clinical Trial Site

111 Registered trials

45 Currently recruiting

Organisation

Institute For Clinical And Experimental Medicine

Location

Prague, Czechia

Identifier

ORG-100013075

Address

Videnska 800, Kunratice, 148 00, Czechia

Departments

#5001:Klinika anesteziologie a resuscitace
1105: Oddělení neinvazivní kardiologie
203001:Klinika kardiologie
2326: Klinika kardiologie
3051: Klinika nefrologie
3056:Oddělení srdečního selhání
Acute cardiology department
Cardiology
Cardiology Clinic
cardiology department
Centrum diabetologie
Centrum diabetologie
Centrum preventivní medicíny
Centrum pro léčbu plicní hypertense, klinika kardiologie
Clinic of Cardiology
Clinics of Hepatogastroenterology
Department of Cardiology
Department of Hepatogastroenterology
Diabetes
diabetology
Diabetology Center
Dialysis Unit
Dialyzační a metabolické oddělení KN
Hepatogastroenterology department
IKEM
IKEM - Klinika kardiologie
IKEM, Centrum diabetologie, Vídeňská 1958/9, 140 21 Praha 4
Institut Klinické a Experimentální Medicíny (IKEM)
Institut klinické a experimentální medicíny Klinika hepatogatroenterologie
Institut klinicke a experimentalni mediciny Klinika nefrologie
Institut klinické a experimentální medicíny,Centrum diabetologie,Vídeňská 1958/9,140 00 Praha-Krč
Kardiocentrum IKEM
Kardiocentrum Klinika kardiologie
Kardiologická klinika
Klinika anesteziologie a resuscitace
Klinika anesteziologie, resuscitace a int. péče (KARIP)
Klinika hepatogastroenterologie
Klinika hepatogastroenterologie, Vídeňská 1958/9 140 21 Praha 4, Czech Republic
Klinika hepatogastroentrologie
Klinika kardiologie
Klinika kardiologie / Cardiology clinic
Klinika kardiologie Ambulance plicní hypertenze
Klinika kardiologie,/ Department of Cardiology
Klinika nefrologie
N/A
NA
Nephrology
Obesitology center
Oddeleni srdecniho selhani
PISA - Pracoviste preventivni kardiologie
Pracoviště preventivní kardiologie
Pracoviste preventivni kardiologie PISA
preventivní kardiologie
Trabsplantcentrum, Klinika nefrologie
Transplant Centre and Nephrology
Transplantcentrum, Klinika nefrologie

Clinical trials at this site (111)

Search interface

TRITON-CM: A Study to Evaluate Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Recruiting

2024-519917-72-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2025-10-29
FORTIFY – Focused Orticumab Research for Treating inflammation in Coronary Arteries Recruiting

2025-520464-17-00 Atherosclerotic Cardiovascular disease 4 2025-10-21
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) Recruiting

2024-513613-12-00 Part A: Healthy volunteers (Part A is not applicable to 9 2025-09-18
A Trial to Test How AZD0780 Affects Serious Heart, Stroke, or Vascular Problems in Patients with Heart, Stroke or Vascular Disease or at Hig… Recruiting

2025-520519-14-00 Atherosclerotic Cardiovascular Disease 5 2025-09-03
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme… Recruiting

2023-508875-35-00 Heart condition 5 2025-09-01
A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta I… Recruiting

2024-517167-23-00 Chronic Hepatitis D Infection 5 2025-08-28
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure and a weak pumping functio… Recruiting

2024-519525-38-00 Heart failure 5 2025-08-22
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis Recruiting

2023-503634-50-01 Anemia in patients with chronic kidney disease on dialy 5 2025-07-22
Phase 3 Study of Ravulizumab versus Placebo in Adult Participants at High Risk of DGF after Kidney Transplantation (AWAKE) Recruiting

2024-517568-48-00 Delayed Graft Function after Kidney Transplantation 5 2025-07-21
A phase III, randomized, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in iron-deficien… Recruiting

2024-519059-28-00 Chronic Heart Failure 5 2025-07-17
A research study comparing CDR132L with placebo on the structure and function of the heart in people with heart failure with reduced/mildly … Recruiting

2024-515797-27-00 Heart Failure with Reduced/Mildly Reducede Ejection Fra 4 2025-06-25
REscue of Nephrons with ALe.F02 (RENAL F02) Recruiting

2022-502184-38-00 Rapidly progressive glomerulonephritis 4 2025-06-06
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo … Recruiting

2023-507560-39-00 Acquired Antithrombin Deficiency (Heparin Resistance) 5 2025-01-07
A Phase 2 study to Evaluate the Safety, Tolerability and Efficacy of Efgartigimod PH20 SC given by prefilled syringe in Kidney Transplant Re… Recruiting

2023-508180-72-00 Antibody-Mediated Rejection 4 2024-12-11
A trial to test the effect of obicetrapib/ezetimibe on coronary plaque characteristics on coronary computerized tomography angiography in pe… Recruiting

2023-508475-36-00 Atherosclerotic Cardiovascular Disease 5 2024-10-29
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Recruiting

2023-509706-30-00 Heart failure (HF) 5 2024-10-18
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on… Recruiting

2022-502135-19-00 Calcific Aortic Valve Stenosis 4 2024-07-18
Grafalon®therapy within 12 weeks of Type 1 diabetes (T1D) diagnosis in children and young adults to prevent the loss of residual beta cell f… Recruiting

2023-508514-42-00 Type 1 diabetes 4 2024-06-04
A Long-Term Study of Elafibranor in Adult Participants with Primary Biliary Cholangitis (ELFIDENCE) Recruiting

2023-505251-43-00 Primary Biliary Cholangitis 5 2024-02-28
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma… Recruiting

2022-501943-34-00 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 5 2023-06-27
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Recruiting

2022-502415-11-00 Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) 5 2023-06-16